AscellaHealth, a global partner delivering customisable solutions to support the specialty pharmaceutical industry, has announced the acquisition of CHAPPER healthcare, a global specialty pharmaceutical wholesaler, distributor and services provider established in 1975.

Bill Oldham, Chairman and President of AscellaHealth, commented: “Our combined experience, expertise and capabilities strengthen the AscellaHealth customer value proposition for delivering innovative, end-to-end solutions and providing our market-leading patient support programmes throughout the world.”

Mario Patone, CFO of AscellaHealth, added: “A strategic transaction in the UK with access to global markets underscores our shared commitment to shaping the future of healthcare, driving business growth and expanding our international presence. This acquisition will significantly accelerate the global market reach and operational scale of both organisations.”

Specialty drug manufacturers and patients benefit from effective supply management of named patient medicines, including unlicensed and orphan drugs for rare diseases. The company’s global network sources and procures a wide range of products, managing shipping processes, temperature controls, customs regulations and the critical timing needed to ensure patients receive their treatments on time.

Jonathan Chapper, CEO of CHAPPER healthcare, said: “We are excited about the opportunity to join forces with the impressive AscellaHealth team and advance global access to vital medicines, particularly in times of urgent need. This is an opportunity to further strengthen our international market impact and serve the expanding AscellaHealth partner portfolio. Together, we are positioned to accelerate our mission of breaking down barriers to care while driving meaningful and sustainable advancements in the global specialty pharmaceutical landscape.”

The ITIJ team recently discussed cultivating personalised care for international patients with Dr Abdul Aziz Aadam, Medical Director at Northwestern.